Using hypercapnia and carbogen as functional markers of vessel maturation and function, we compared blood oxygen level-dependent (BOLD) contrast with standard dynamic contrast-enhanced (DCE)-MRI quantitative parameters in murine fibrosarcoma. Our results show that there was no correlation between vessel maturity and contrast-agent uptake rate (K(in) (Trans)) or contrast agent efflux rate (k(ep)). In addition, DCE-MRI provided higher estimates of the fraction of functional tumor compared to BOLD-MRI. The two putative markers of regional vascular density, i.e., the magnitude of BOLD signal change during carbogen challenge (VF) and the fractional plasma volume found by DCE-MRI (V(p)), were only weakly correlated (r(2) = 0.02-0.14). Furthermore, VF showed no correlation with K(in) (Trans). A positive correlation was observed (r(2) = 0.75) between mean tumor VF and k(ep), but only when averaged over the whole tumor (which includes tumor regions completely unperfused by the gadolinium (Gd) contrast agent). This would merely reveal a relationship between perfusion status and the capacity to respond to carbogen breathing. In conclusion, characterizations of tumor microvasculature imaging using BOLD-MRI and DCE-MRI appear to be largely complementary, given the weak correlations between their corresponding derived parameters.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mrm.21047DOI Listing

Publication Analysis

Top Keywords

bold-mri dce-mri
8
kin trans
8
contrast agent
8
tumor
6
dce-mri
5
determination maturity
4
maturity functionality
4
functionality tumor
4
tumor vasculature
4
vasculature mri
4

Similar Publications

Breast cancer is one of the most prevalent forms of cancer affecting women worldwide. Hypoxia, a condition characterized by insufficient oxygen supply in tumor tissues, is closely associated with tumor aggressiveness, resistance to therapy, and poor clinical outcomes. Accurate assessment of tumor hypoxia can guide treatment decisions, predict therapy response, and contribute to the development of targeted therapeutic interventions.

View Article and Find Full Text PDF
Article Synopsis
  • - The marrow-blood barrier (MBB) regulates how mature blood cells and other substances move between the bone marrow and the bloodstream, playing a vital role in blood cell distribution.
  • - Damage to the MBB can lead to increased permeability, which is often seen in blood diseases and tumors as immature cells are found in the blood.
  • - Various imaging techniques like DCE-MRI, IVIM, ASL, BOLD-MRI, and microfluidic devices are used to assess the MBB's integrity, helping inform disease understanding and treatment strategies.
View Article and Find Full Text PDF

Solid renal masses (SRMs) are increasingly detected and encompass both benign and malignant masses, with renal cell carcinoma (RCC) being the most common malignant SRM. Most patients with SRMs will undergo management without a priori pathologic confirmation. There is an unmet need to noninvasively diagnose and characterize RCCs, as significant variability in clinical behavior is observed and a wide range of differing management options exist.

View Article and Find Full Text PDF

Introducing a New Biomarker Named R2*-BOLD-MRI Parameter to Assess Treatment Response in Osteosarcoma.

J Magn Reson Imaging

August 2022

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Background: While histologic response to neoadjuvant chemotherapy (NChT) is the major prognostic factor for osteosarcoma treatment, evaluating that response is difficult.

Purpose: To evaluate the feasibility of the blood oxygen level-dependent (BOLD) technique to assess the response to NChT.

Study Type: Prospective.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!